Naidech et al.1 concluded that increased prophylactic antiseizure drug (ASD) use in intracranial hemorrhage (ICH) between 2007 and 2012 was due to clinicians' hesitation to abandon a longstanding practice despite an established guideline.2 We offer an additional interpretation.
from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader http://ift.tt/2wezV4S
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.